Gibraltar Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-23,642
Closed -$4.52M 55
2019
Q4
$4.52M Sell
23,642
-686
-3% -$124K 2.72% 15
2019
Q3
$4.09M Sell
24,328
-1,903
-7% -$310K 3.09% 12
2019
Q2
$4.39M Buy
26,231
+230
+0.9% +$31.8K 4.53% 5
2019
Q1
$3.81M Buy
26,001
+18,295
+237% +$2.65M 3.82% 9
2018
Q4
$1.03M Sell
7,706
-25,554
-77% -$4.19M 1.09% 21
2018
Q3
$6.33M Buy
33,260
+201
+0.6% +$36.9K 4.97% 9
2018
Q2
$5.51M Buy
33,059
+556
+2% +$89.3K 4.65% 12
2018
Q1
$5.47M Buy
32,503
+17,846
+122% +$2.99M 4.64% 11
2017
Q4
$2.4M Sell
14,657
-13,382
-48% -$2.4M 1.9% 20
2017
Q3
$5.75M Buy
28,039
+983
+4% +$229K 5.07% 7
2017
Q2
$6.58M Buy
27,056
+891
+3% +$209K 6.58% 6
2017
Q1
$6.25M Buy
26,165
+50
+0.2% +$11.6K 5.87% 5
2016
Q4
$5.48M Buy
26,115
+9,943
+61% +$2.06M 5.1% 5
2016
Q3
$3.73M Buy
16,172
+102
+0.6% +$24.9K 4.31% 11
2016
Q2
$3.71M Buy
+16,070
New +$3.71M 4.57% 11

Other funds holding AGN

Gibraltar Capital Management's AGN Position: Q1 2020 in Review

Gibraltar Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 23,642 shares — an estimated $4.52M sold.

Gibraltar Capital Management first reported a position in AGN in Q2 2016 and held it in 15 quarters. The position peaked at $6.58M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Gibraltar Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Gibraltar Capital Management sold 23,642 Allergan plc shares in Q1 2020, an estimated $4.52M.
  • Gibraltar Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 15 quarters.
  • Gibraltar Capital Management's Allergan plc position peaked at $6.58M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Gibraltar Capital Management's 13F filing for Q1 2020, filed 16 Apr 2020.